Details of the Drug

General Information of Drug (ID: DMU5761)

Drug Name
PF-06282999
Indication
Disease Entry ICD 11 Status REF
Acute coronary syndrome BA41 Phase 1 [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C13H12ClN3O3S
Canonical SMILES
COC1=C(C=C(C=C1)Cl)C2=CC(=O)NC(=S)N2CC(=O)N
InChI
InChI=1S/C13H12ClN3O3S/c1-20-10-3-2-7(14)4-8(10)9-5-12(19)16-13(21)17(9)6-11(15)18/h2-5H,6H2,1H3,(H2,15,18)(H,16,19,21)
InChIKey
ICYNYWFGIDGBRD-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
71571306
ChEBI ID
CHEMBL3633460
CAS Number
1435467-37-0
UNII
YO3O4Q2NC8
DrugBank ID
DB11683
TTD ID
D09DXX
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 ClinicalTrials.gov (NCT01626976) A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects. U.S. National Institutes of Health.